Travere Therapeutics (TVTX) total assets

Total assets · fiscal 2025
$605.19M

Travere Therapeutics (TVTX) had total assets of $605.19M at the end of fiscal 2025 (December 31, 2025). That is 1.9% higher than the $594.13M of fiscal 2024. Figures as of 18 Nov 2026, 07:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$605.19M
Change on fiscal 2024
+1.9%
Growth, 5 years
−0.1% a year
Growth, 10 years
+1.7% a year
Highest on record
$788.91Mfiscal 2023
Lowest on record
$2.39Mfiscal 2012
Fiscal years on record
142012–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Travere Therapeutics total assets, in more detail

Over the five fiscal years to 2025 total assets shrank at a compound 0.1% a year; over ten years the rate was 1.7% a year. Across the 14 fiscal years on record (2012–2025), the highest was $788.91M in fiscal 2023 and the lowest $2.39M in fiscal 2012.

History · 14 fiscal years

Total assets by fiscal year

Travere Therapeutics total assets, year by year

Travere Therapeutics (TVTX) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$605.19M 1.9% up
2024$594.13M 24.7% down
2023$788.91M 17.3% up
2022$672.59M 13.4% down
2021$776.63M 27.9% up
2020$607.44M 0.4% up
2019$604.80M 14.7% down
2018$709.16M 36.3% up
2017$520.35M 0.9% down
2016$525.28M 2.5% up
2015$512.26M 278.1% up
2014$135.47M 560.9% up
2013$20.50M 757.2% up
2012$2.39M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Travere Therapeutics and comparable companies
CompanyTotal assetsFiscal year
MiniMed Group MMED$4.63B2026
Adaptive Biotechnologies ADPT$512.74M2025
Heartflow HTFL$359.45M2025
CRISPR Therapeutics CRSP$2.27B2025
Travere Therapeutics TVTX$605.19M2025
Option Care Health OPCH$3.46B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TVTX

Travere Therapeutics, figure by figure

Travere Therapeutics (TVTX) overview: price, valuation and scorecardAll health care companies by market value

Travere Therapeutics total assets: questions and answers

How large are Travere Therapeutics's total assets?

Travere Therapeutics (TVTX) had total assets of $605.19M at the end of fiscal 2025 (December 31, 2025). That is 1.9% higher than the $594.13M of fiscal 2024.

What is the growth rate of Travere Therapeutics's total assets?

Over the five fiscal years to 2025 total assets shrank at a compound 0.1% a year; over ten years the rate was 1.7% a year.

What are the highest and lowest total assets figures on record for Travere Therapeutics?

Across the 14 fiscal years on record (2012–2025), the highest was $788.91M in fiscal 2023 and the lowest $2.39M in fiscal 2012.

How is Travere Therapeutics's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Travere Therapeutics (TVTX) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/TVTX/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.